| Literature DB >> 34769298 |
Krzysztof J Pawlik1, Mateusz Zelkowski1, Mateusz Biernacki1, Katarzyna Litwinska1, Pawel Jaworski1, Magdalena Kotowska1.
Abstract
Streptomyces bacteria produce a plethora of secondary metabolites including the majority of medically important antibiotics. The onset of secondary metabolism is correlated with morphological differentiation and controlled by a complex regulatory network involving numerous regulatory proteins. Control over these pathways at the molecular level has a medical and industrial importance. Here we describe a GntR-like DNA binding transcription factor SCO3932, encoded within an actinomycete integrative and conjugative element, which is involved in the secondary metabolite biosynthesis regulation. Affinity chromatography, electrophoresis mobility shift assay, footprinting and chromatin immunoprecipitation experiments revealed, both in vitro and in vivo, SCO3932 binding capability to its own promoter region shared with the neighboring gene SCO3933, as well as promoters of polyketide metabolite genes, such as cpkD, a coelimycin biosynthetic gene, and actII-orf4-an activator of actinorhodin biosynthesis. Increased activity of SCO3932 target promoters, as a result of SCO3932 overproduction, indicates an activatory role of this protein in Streptomyces coelicolor A3(2) metabolite synthesis pathways.Entities:
Keywords: AICEs; GntR; HutC; KorSA; kil-kor system; specialized metabolism regulation; streptomyces
Mesh:
Substances:
Year: 2021 PMID: 34769298 PMCID: PMC8584621 DOI: 10.3390/ijms222111867
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
S. coelicolor A3(2) regulatory proteins interacting with bait fragments, detected by mass spectrometry.
| Nr | Protein Name | Mass [Da] | Score | Matches | emPAI * |
|---|---|---|---|---|---|
| 1 | hypothetical protein SCO7102 | 19196 | 987 | 19 | 2.40 |
| 2 | transcriptional regulator GntR type SCO3932 | 28559 | 386 | 13 | 2.15 |
| 3 | DNA binding protein SCO1926 | 27119 | 112 | 2 | 0.25 |
| 4 | transcriptional regulator IclR type SCO1872 | 28494 | 107 | 2 | |
| 5 | DNA binding protein SCO6003 | 31958 | 94 | 1 |
* Exponentially Modified Protein Abundance Index.
Oligonucleotides used in this work. Gene numbers according to Bentley et al. 2002 [5]. Restriction sites are in bold.
| Primer | Sequence | Amplified Fragment; Description |
|---|---|---|
| Sc3932FW | GGATCCCATATGACGGAGATCCAGCGC | gene |
| Sc3932RV | GAATTCTCAAAGCTTGGTCTGGCGGCGTCGGGT | |
| 3932LRFw | AAGCTTACGTGGTGAACCATGCAGT | |
| 3932LRRv | CTGCAGAGACCTGACCGGCGA CGA | |
| 3932PRFw | GGATCCGGCGAACTCGCCCGAAAG | |
| 3932LRFw | AAGCTTACGTGGTGAACCATGCAGT | |
| p3932FW | GGGAATGGACTGCATTTCTG | p3932/3933; |
| p3932RV | GAACTCGCCCGAAAGGAT | |
| FPrv3932 | AAGAATTCTGGATCTCCGTCATCTC | detection of |
| FPfw3932 | AAGGATCCGAATGGACTGCATTTCTG | |
| CTR1-BT | biotin-TCGCCTGGAGAACGGGCC | control fragment, biotinylated |
| CTR2 | CGGAATTCGTCGACGGAGCCACCGGCTTC | |
| CTR3 | CGTTAAATGCCTGGACTGTG | control fragment in ChIP-PCR experiment |
| CTR4 | TGTAGCGGATGCCGATGTT | |
| AD1-BT | biotin-GTGACGTTCGCGAAGGTCTCG | pcpkA/D-BT; |
| AD2 | GACAGTCCCACGACAGCGATC | |
| AD3 | CGACCCGAATCCTCTTCCAGA | primer for footprint |
| AD4 | GAAGGTCTCGGAGAGAGCAC | pcpkA/D; |
| AD5 | CAGGACAGTCCCACGACAG | |
| AD6 | GGAGAAAAGGCCCGCCATGCT | primer used together with AD3 for detection of |
| pact-fw | CGCTCGCCCGGCGCGAGGACCCTTC | pactII-orf4; promoter of gene |
| pact-rv | TGAGGAGCAGCAGCACCAGGAGCTG | |
| pactII-orf4_Bam_F | GGATCCCTGCTGATCGCGAGCGTGG | promoter of gene |
| pactII-orf4_Nde_R | CATATGCGCCCCCGTCGAGATTCTC | |
| pTZBAM-800 | IRD800-ATGCAGGCCTCTGCA | IRDye 800 labeled primers flanking the cloning site of pTZ57R/T vector |
| pTZXBA-800 | IRD800-TCGGTACCTCGCGAA |
Figure 1Binding of SCO3932 protein to the intergenic region between SCO3932 and SCO3933 genes. (a) Electrophoretic mobility shift assay with p3932/3933 fragment. Lanes 0–7 contain 0, 0.9, 1.8, 9.4, 18, 28, 47 and 94 nM SCO3932 protein, respectively. Lanes S and NS contain ten-fold excess of the specific and nonspecific competitor DNA, respectively, and 94 nM SCO3932 protein; (b) DNase I and DMS footprinting of SCO3932 binding to SCO3932 and SCO3933 promoter region. The concentrations of SCO3932 protein used were 0, 50, 100, 200, 400, 800, 0 nM in the consecutive lines. Lanes G, A, T, C correspond to the sequence ladder generated with the labeled primer. The regions protected from cleavage by DNase I are indicated (sites K1, K2). On DMS footprint guanines protected from cleavage are marked with small arrows; (c) DNA sequence of the SCO3932 and SCO3933 promoter region. Primers are marked with horizontal arrows. Coding sequences are in bold, and gene orientation is shown with <, >. Translational start codons are marked with boxes. Bent arrow denotes transcriptional start site (TSS) according to Jeong et al., 2016 [25]. The sequences protected by SCO3932 from cleavage (sites K1, K2) are indicated by the shaded boxes. Protected guanines are marked with small arrows. Sequence repeats (with one mismatch) are in red. Sequence corresponding to the common motif identified by MEME (see Figure 4) is underlined and in italic.
Figure 2Binding of SCO3932 protein to the intergenic region between cpkA and cpkD genes. (a) Electrophoretic mobility shift assay with pcpkA/D fragment. Lanes 0–7 contain 0, 0.9, 1.8, 9.4, 18, 28, 47 and 94 nM SCO3932 protein, respectively. Lane S—ten-fold excess of the specific competitor DNA, lane NS ten-fold excess of nonspecific competitor DNA, respectively, and 94 nM SCO3932 protein; (b) DNase I footprinting of SCO3932 binding to the pcpkD promoter region. The amounts of SCO3932 used in the footprint were 0, 100, 200, 400, 800 1600, 0 nM. The region protected from cleavage by DNase I is indicated (site D). Lanes G, A, T, C correspond to the sequence ladder generated with the labelled primer. (c) DNA sequence of the cpkD promoter region. Primers are marked with horizontal arrows. Coding sequence is bold, translational start codon is marked with a box. Bent arrow denotes transcriptional start site (TSS) according to Jeong et al., 2016 [25]. The −35 and −10 regions are underlined with a dashed line. The sequence protected by SCO3932 from cleavage (site D) is indicated by the shaded box. Sequence corresponding to the common motif identified by MEME (see Figure 4) is underlined and in italic.
Figure 3Binding of SCO3932 protein to the promoter region of actII-orf4. (a) Electrophoretic mobility shift assay. Lanes 0–7 contain 0, 0.9, 1.8, 9.4, 18, 28, 47 and 94 nM SCO3932 protein, respectively. Lanes S and NS contain ten-fold excess of the specific and nonspecific competitor DNA, respectively, and 94 nM SCO3932 protein; (b) DNase I footprinting of SCO3932 binding to the actII-orf4 promoter region. The amounts of SCO3932 used were 0, 100, 200, 400, 800 1600 nM. The regions protected from cleavage by DNase I are indicated (sites A1, A2). Lanes G, A, T, C correspond to the sequence ladder generated with the labelled primer. (c) DNA sequence of the actII-orf4 promoter region. Primers are marked with horizontal arrows. Coding sequence is bold, translational start codon is marked with a box. Bent arrow denotes transcriptional start site (TSS) according to Jeong et al., 2016 [25]. The −35 and −10 regions are underlined with a dashed line. The sequences protected by SCO3932 from cleavage (sites A1, A2) are indicated by the shaded boxes. Sequence corresponding to the common motif identified by MEME (see Figure 4) is underlined and in italic.
Figure 4Common sequence motif found by the MEME algorithm within the SCO3932 binding sites identified in DNase I footprint experiments.
Figure 5Chromatin immunoprecipitation. Nucleoprotein complexes crosslinked with glutaraldehyde were precipitated by anti-SCO3932 polyclonal antibodies, and DNA fragments were amplified by PCR with primers listed in Table 2. SCO3932 overexpression in P171 was induced by thiostrepton (8 μg/mL). 32/33—SCO3932/SCO3933 promoter, cpk—cpkD promoter, act—actII-orf4 promoter, K—control fragment, M—1 kb Plus DNA Ladder (Thermo Fisher Scientific).
Figure 6Effects of SCO3932 overexpression. (a) Activity of cpkD and actII-orf4 promoters measured in the luciferase reporter assay, P170—strain overexpressing SCO3932, P123—control strain, standard deviation was shown for every 10 h time-point for clarity; (b) Phenotypic effects of SCO3932 overexpression induced by thiostrepton in the concentration 0, 2, 4, 8 μg/mL (as indicated) on 79 and 79NG media, P171—strain overexpressing SCO3932, P106—control strain.
Bacterial strains and plasmids used in this study.
| Strain or Plasmid | Relevant Genotype or Description | Source or Reference |
|---|---|---|
|
| ||
| DH5α | F- | Promega |
| BL21(DE3)pLysS | F-, | Promega |
| ET12567/pUZ8002 | strain for conjugal transfer of DNA from | [ |
|
| ||
| M145 | wild type strain, a plasmidless variant of | [ |
| P170 | overproduction of SCO3932 from a strong constitutive promoter | this work |
| P123 | control with empty plasmid (M145 + pCJW93) | this work |
| P171 | overproduction of SCO3932 from a thiostrepton inducible promoter P | this work |
| P106 | control with empty plasmid (M145 + pIJ6902) | this work |
| M145 and P171 derivatives for luciferase reporter assay | M145 and P171 harbouring either pFLUXH-pcpkD or pFLUXH-pactII-orf4 | this work |
|
| ||
| pTZ57R/T | T-vector from InstT/A Cloning kit for direct cloning of PCR products | Thermo Fisher Scientific |
| pGEM-T Easy | T-vector for direct cloning of PCR products | Promega |
| pET21b | plasmid for expression of proteins with C-terminal His-tag (T7 promoter, AmpR) | Novagen |
| pCJW93 | high copy number plasmid, ApraR ( | [ |
| pWP3 | pCJW93 in which P | this work |
| pIJ6902 | integrative vector, AprR ( | [ |
| pIJ10257 | ΦBT1 integrating overexpression plasmid containing strong constitutive promoter | [ |
| pMZ10 | gene | this work |
| pMZ16 | gene | this work |
| pKL20 | gene | this work |
| pKL21 | gene | this work |
| pOJ260 | vector for conjugal transfer from | [ |
| pMB12 | pOJ260 with the | this work |
| pMB13 | pOJ260 with the | this work |
| pMB14 | pOJ260 with the neomycin resistance cassette cloned between the | this work |
| pTZ-pactII-orf4 | promoter of | this work |
| pTZ-pcpkA/D | fragment pcpkA/D, amplified with primers AD4 and AD5, in pTZ57R/T | this work |
| pTZ-p3932 | fragment p3932/33, amplified with primers FPrv3932 and FPfw3932, in pTZ57R/T | this work |
| pTZ57R-T-pactII-orf4 | promoter of | this work |
| pFLUXH | ΦBT1 integrating reporter plasmid with a promoterless luciferase operon | [ |
| pFLUXH-pcpkD | pFLUXH containing promoter region of | [ |
| pFLUXH-pactII-orf4 | promoter region of | this work |